MapLight Therapeutics (MPLT) Interest & Investment Income (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Interest & Investment Income came in at $2.5 million in Q4 2025, up 174.75% year-on-year from $899000.0 in Q4 2024, and up 59.46% quarter-over-quarter from $1.5 million in Q3 2025.
MapLight Therapeutics (MPLT) Interest & Investment Income (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Interest & Investment Income across 2 years of filings, most recently posting $2.5 million for Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $2.5 million, up 174.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.0 million (changed N/A YoY), and the FY2025 annual result was $5.5 million, up 22.51% from the prior year.
- Interest & Investment Income came in at $2.5 million for Q4 2025 at MapLight Therapeutics, up from $1.5 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.5 million in Q4 2025 to a low of $899000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | 2.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Dec 31, 2024 | 899,000.00 |
| Sep 30, 2024 | 1.08 Mn |